| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Agenus Inc last filed a Form 4 in October 2023, as 10% Owner at INKT.
At the last filing, the largest reported position was 21,772,863 shares of INKT. Net of sales, the INKT filings show accumulation of 1,946,494 shares.
Agenus Inc has 8 Form 4 filings on record from October 2021 to October 2023, all as 10% Owner at MiNK Therapeutics (INKT), 2021–2023.
The 16 reported transactions were 14 open-market purchases, 1 other transaction and 1 conversion.
Counted by filing, the open-market trades come to 7 purchases worth about $17.5M and no sales.
The largest open-market purchase was 1,400,000 shares of INKT at an average $12.00 on October 19, 2021, about $16.8M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 22,975 | $1.10 | $25,270.25 | +0.1% | - | - | |
| Oct 4, 2023 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 15,001 | $1.09 | $16,379.59 | - | - | - | |
| Aug 29, 2023 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 29,678 | $1.52 | $45,015.59 | +0.1% | - | - | |
| Aug 28, 2023 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 183,052 | $1.54 | $281,478.13 | +0.9% | - | - | |
| May 11, 2023 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 45,426 | $1.47 | $66,643.91 | +0.2% | - | - | |
| May 5, 2023 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 250,362 | $1.04 | $260,189.01 | +1.2% | +8.9% | -38.0% | |
| Oct 19, 2021 | INKT Mink Therapeutics, Inc. | 10% Owner | Buy | 1,400,000 | $12.00 | $16,800,000.00 | +7.2% | - | - |